Clinical trial
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in…
NCT00002941 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002941 |
|---|---|
| Title | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma |
| Official title | A Pilot Study of Peripheral Blood Stem Cell Transplantation (PBSCT) After Preparative Therapy Consisting of Cyclophosphamide, BCNU, and Etoposide (CBV) for Recurrent and Primarily Refractory Hodgkin's and Non-Hodgkin's Lymphoma |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | carmustine, cyclophosphamide, etoposide, mesna, peripheral blood stem cell transplantation |
| Enrollment | 69 |
| Start date | Apr 1, 1998 |
| Primary completion | Nov 1, 2002 |
| Completion | Mar 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 1, 2014 |
| Countries | Australia, Canada, Netherlands, New Zealand, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: